FIRST TRUST ADVISORS LP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2023$3,457,391
+29.3%
333,725
+47.3%
0.00%
+33.3%
Q4 2022$2,674,823
-12.9%
226,488
+54.8%
0.00%
-25.0%
Q3 2022$3,071,000
-27.2%
146,318
+7.7%
0.00%
-20.0%
Q2 2022$4,216,000
-15.7%
135,828
+11.5%
0.01%0.0%
Q1 2022$5,000,000
+27.3%
121,782
+34.8%
0.01%
+25.0%
Q4 2021$3,927,000
+447.7%
90,331
+530.5%
0.00%
+300.0%
Q3 2021$717,000
-71.0%
14,326
-63.5%
0.00%
-66.7%
Q2 2021$2,470,000
-32.6%
39,206
-0.5%
0.00%
-25.0%
Q1 2021$3,662,000
-24.1%
39,416
-26.8%
0.00%
-33.3%
Q4 2020$4,826,000
+198.6%
53,863
+92.9%
0.01%
+50.0%
Q1 2020$1,616,000
-35.9%
27,929
-40.2%
0.00%0.0%
Q4 2019$2,520,000
+82.5%
46,701
+76.7%
0.00%
+33.3%
Q3 2019$1,381,000
-57.1%
26,424
-58.5%
0.00%
-50.0%
Q1 2019$3,216,000
-20.5%
63,662
-6.8%
0.01%
-40.0%
Q4 2018$4,047,000
+144.1%
68,273
+171.0%
0.01%
+233.3%
Q3 2018$1,658,000
-40.7%
25,193
-54.5%
0.00%
-50.0%
Q2 2018$2,794,000
+25.6%
55,344
+30.9%
0.01%
+20.0%
Q1 2018$2,225,000
+13.8%
42,265
+0.4%
0.01%0.0%
Q4 2017$1,956,000
+35.2%
42,085
+17.7%
0.01%
+25.0%
Q3 2017$1,447,000
-19.7%
35,762
-32.7%
0.00%
-20.0%
Q2 2017$1,802,000
+214.5%
53,149
+169.2%
0.01%
+150.0%
Q1 2017$573,000
-37.0%
19,746
-28.7%
0.00%
-33.3%
Q4 2016$909,000
-19.4%
27,677
-31.0%
0.00%
-25.0%
Q2 2016$1,128,000
-42.1%
40,129
-25.1%
0.00%
-33.3%
Q1 2016$1,947,000
-20.5%
53,562
-12.5%
0.01%0.0%
Q4 2015$2,449,000
-15.2%
61,203
-39.6%
0.01%
-25.0%
Q3 2015$2,888,000
-9.4%
101,359
+4.7%
0.01%0.0%
Q2 2015$3,188,000
+1.4%
96,764
-11.5%
0.01%
-11.1%
Q1 2015$3,144,000
+144.9%
109,319
+131.9%
0.01%
+125.0%
Q4 2014$1,284,000
+31.2%
47,150
+2.6%
0.00%0.0%
Q3 2014$979,000
-44.0%
45,960
-41.0%
0.00%
-42.9%
Q2 2014$1,749,000
+10.2%
77,889
+24.1%
0.01%0.0%
Q1 2014$1,587,000
+46.7%
62,783
+33.4%
0.01%
+40.0%
Q4 2013$1,082,000
-10.5%
47,050
-25.8%
0.01%
-28.6%
Q3 2013$1,209,000
+62.7%
63,443
+23.1%
0.01%
+40.0%
Q2 2013$743,00051,5460.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders